Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Dig Dis Sci. 2009 Jun 9;55(5):1396–1405. doi: 10.1007/s10620-009-0839-8

Figure 4.

Figure 4

Immunohistochemistry (IHC) for FOXP3 and CD3 revealed a trend towards more Tregs (A) and T cells (B), respectively, infiltrating the colonic mucosa of ipilimumab recipients who developed diarrhea than in those who did not. However, IHC did not show a lower fraction of these T cells to be FOXP3+ Tregs in ipilimumab recipients relative to controls, nor in ipilimumab recipients who developed diarrhea relative to those who did not (C). P-values were calculated by two-tailed unpaired Student's t-test.